Chinook Therapeutics Inc (KDNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -62,957 | -42,005 | -23,427 | -95,357 | -69,037 |
| Depreciation Amortization | 7,312 | 1,598 | 875 | 7,878 | 2,911 |
| Income taxes - deferred | -2,320 | -70 | -35 | -146 | -99 |
| Accounts receivable | 11,815 | 10,674 | 11,330 | -11,048 | 989 |
| Accounts payable and accrued liabilities | 409 | -349 | 202 | 533 | -26 |
| Other Working Capital | 2,550 | 4,217 | 7,456 | 730 | -15,486 |
| Other Operating Activity | -248 | -1,651 | -7,610 | 28,651 | 13,082 |
| Operating Cash Flow | $-43,439 | $-27,586 | $-11,209 | $-68,759 | $-67,666 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,183 | -382 | -424 | -2,324 | -1,997 |
| Purchase Of Investment | -224,927 | -133,478 | -77,790 | -226,953 | -179,277 |
| Sale Of Investment | 196,410 | 114,159 | 76,103 | 268,684 | 214,314 |
| Investing Cash Flow | $-29,700 | $-19,701 | $-2,111 | $39,407 | $33,040 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 696 | 603 | 251 | 1,986 | 1,694 |
| Other Financing Activity | 0 | 0 | 0 | -3,481 | -3,481 |
| Financing Cash Flow | $696 | $603 | $251 | $-1,495 | $-1,787 |
| Exchange Rate Effect | -262 | -65 | -127 | -457 | -450 |
| Beginning Cash Position | 126,778 | 126,778 | 126,778 | 158,082 | 158,082 |
| End Cash Position | 54,073 | 80,029 | 113,582 | 126,778 | 121,219 |
| Net Cash Flow | $-72,705 | $-46,749 | $-13,196 | $-31,304 | $-36,863 |
| Free Cash Flow | |||||
| Operating Cash Flow | -43,439 | -27,586 | -11,209 | -68,759 | -67,666 |
| Capital Expenditure | -1,183 | -382 | -424 | -2,365 | -2,007 |
| Free Cash Flow | -44,622 | -27,968 | -11,633 | -71,124 | -69,673 |